SAT-233 - Gensci134, A Long-Acting GHR-Agonistic VHH-Fc Fusion Protein, Demonstrates Sustained GH-Mimetic Activity and Enhanced Metabolic and Skeletal Effects in Preclinical Models

Abstract Poster Presenter(s)

• AM

  AN MENGYAO, scientist

  SHANGHAI, China

Co-Author(s)

• NL

  NA LIU, scientist

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)

Senior Author/Primary Investigator(s)

• XW

  XIAOZHEN WANG, n/a

  VP
  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)

Co-Author(s)

• HZ

  Haizhou Zhang, Ph.D.

  GeneScience Pharmaceuticals
  shanghai, China (People's Republic)
• PQ

  Peng Qi, scientist

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• QM

  Qingjuan Ma, scientist

  Changchun GeneScience Pharmaceutical Co., Ltd.
  SHANGHAI, China (People's Republic)
• LK

  LiShan Kang, scientist

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)